Stay updated on Quizartinib vs Chemo in FLT3-ITD (+) AML Clinical Trial

Sign up to get notified when there's something new on the Quizartinib vs Chemo in FLT3-ITD (+) AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Quizartinib vs Chemo in FLT3-ITD (+) AML Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer displays site revision v3.8.0 instead of v3.7.2; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-02T11:42:12.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces FAQs about federal agencies transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-26T11:11:02.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T11:47:37.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-12T14:28:23.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The revision history now shows Revision: v3.7.0 added, replacing Revision: v3.6.6, indicating an updated version of the study record.
    Difference
    0.1%
    Check dated 2026-09-21T20:23:41.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    A new site revision entry (v3.6.6) is added to the history, and the previous revision (v3.6.5) is removed, reflecting a recent update to the page's UI/history.
    Difference
    0.1%
    Check dated 2026-08-31T16:29:50.000Z thumbnail image

Stay in the know with updates to Quizartinib vs Chemo in FLT3-ITD (+) AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Quizartinib vs Chemo in FLT3-ITD (+) AML Clinical Trial page.